Placebo matching empagliflozin and placebo pen injector matching semaglutide clinical trials

Combined Active Treatment in Type 2 Diabetes with NASH

This study is looking at new ways to treat a liver condition called NASH in people with type 2 diabetes. We're testing two medicines, empagliflozin and semaglutide, to see if they can help improve liver health. This is important because there are currently no specific treatments for NASH.